MedPath

Comparative Evaluation of Pulpotomized Primary Molars With Mineral Trioxide Aggregate and New Endodonthic Cement

Phase 3
Conditions
Pulpotomy Treatment
Interventions
Procedure: pulpotomy
Registration Number
NCT00802256
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

A new Endodontic Cement (NEC) is being compared with mineral trioxide aggregate in pulpotomy of primary molars.

Detailed Description

Forty patient are selected randomly. Each patient has at least 2 teeth which require pulpotomy treatment. After removing of carious teeth by a low speed round bur and pulp exposure, roof of pulp chamber is removed completely by a high speed 008 fissure bur. Life tissues of pulp are removed by sharp excavator and rinsing with normal salin. Hemostat is achieved and cavity will be cleaned by 0.5% hypo chlorate solution. MTA or NEC material is mixed according to manufacturer instruction and will be placed in pulp chamber and over pulpal canal orifices for at least 1 mm. The light cure glass inomor is also mixed according to manufacturer instruction and is places over the A or B material and cured for 40 minutes. The treated tooth will be restored with a stainless steel crown or amalgam filling material.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Vital pulp exposure of teeth with caries or trauma
  • No clinical signs & symptoms like pain,inflammation
  • No radiographic signs & symptoms like: internal resorption,external resorption, furcation involvement,pulp canal obliteration.
  • The restorable tooth
  • No dental treatment contraindication
Exclusion Criteria
  • Systemic diseases
  • Existence of pain,inflammation or sinus tract
  • No patient compliance

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bpulpotomyteeth which are treated with new Endodontic Cement (NEC) material
Apulpotomyteeth which are treated with Mineral Trioxide Aggregate (MTA) material
Primary Outcome Measures
NameTimeMethod
Clinical features and radiographic examination6 monthes and one year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saheed Behesti University for Medical sciences

🇮🇷

Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath